Introduction: Radical nephrectomy is the treatment of first choice for unil
ateral renal cell carcinoma (RCC) with a healthy contralateral kidney; howe
ver, the current standard for dealing with RCC in patients with a solitary
kidney, bilateral tumor and renal or systemic disease inducing a progressiv
e impairment of renal function is nephron-sparing surgery. Materials and Me
thods: Between January 1974 and July 1996, 62 patients (39 men and 23 women
, 33-77 years old, mean age 60.6 years) with RCC underwent nephron-sparing
surgery. The patients were divided in to two groups according to treatment
indication: 46 patients with bilateral tumor (n = 21) or solitary kidney (n
= 25) and 16 patients with renal or systemic disease that could damage the
contralateral kidney. Survival curves were calculated according to the Kap
lan-Meyer method. Results: In the first group 3 patients died postoperative
ly, and 3 were lost to follow-up; 12 patients (27.9%) had malignant recurre
nce and 5 (11.6%) died of local recurrence or systemic diffusion. The proba
bility of local or systemic tumor recurrence was 9.9% at 2 years, 20.2% at
5 years and 24.7% at 10 years; the probability of survival was 100% at 2 ye
ars, 91.9% at 5 years and 81.9% at 10 years. In the second group 3 patients
died of unrelated causes and 1 was lost to follow-up; 4 patients (25%) had
a malignant recurrence and 2 (12.5%) died of systemic diffusion of RCC. Th
e probability of tumor recurrence was 13.0% at 2 years, 19.7% at 5 years an
d 26.4% at 10 years, the probability of survival was 100% at 2 years, 93.3%
at 5 years and 86.1% at 10 years. Conclusions: In our experience nephron-s
paring surgery seems justified in patients with a solitary kidney, bilatera
l tumor or a disease that potentially damages renal function. Tumor diamete
r and stage, incidental or symptomatic tumor presentation and specific indi
cation for conservative surgery determine the prognosis. Copyright (C) 2001
S. Karger AG, Basel.